YU
ALXN

Yale University’s Alexion Pharmaceuticals ALXN Stock Holding History

Yale University’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-319,273
Closed -$57.7M – 13
2015
Q2 		$57.7M Buy
+319,273
New +$55.1M 16.37% 3

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Yale University's ALXN Position: Q3 2015 in Review

Yale University sold out of Alexion Pharmaceuticals (ALXN) in Q3 2015, closing a stake of 319,273 shares — an estimated $57.7M sold.

Yale University first reported a position in ALXN in Q2 2015 and held it in 1 quarter. The position peaked at $57.7M in Q2 2015. 515 funds tracked by Wall St. Rank hold ALXN as of Q3 2015.

  • Yale University reported no remaining Alexion Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Yale University sold 319,273 Alexion Pharmaceuticals shares in Q3 2015, an estimated $57.7M.
  • Yale University first reported a position in Alexion Pharmaceuticals in Q2 2015 and held it in 1 quarter.
  • Yale University's Alexion Pharmaceuticals position peaked at $57.7M in Q2 2015.
  • 515 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2015.

Based on Yale University's 13F filing for Q3 2015, filed 13 Nov 2015.